Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial

NCT03855332 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

OTHER

Sponsor class

Conditions

Small Vessel Cerebrovascular Disease

Interventions

DRUG: Sildenafil
DRUG: Cilostazol
DRUG: Placebo

Sponsor

University of Oxford

Collaborators

[object Object]